BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38659056)

  • 41. Prioritizing putative influential genes in cardiovascular disease susceptibility by applying tissue-specific Mendelian randomization.
    Taylor K; Davey Smith G; Relton CL; Gaunt TR; Richardson TG
    Genome Med; 2019 Jan; 11(1):6. PubMed ID: 30704512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Causal roles and clinical utility of cardiovascular proteins in colorectal cancer risk: a multi-modal study integrating mendelian randomization, expression profiling, and survival analysis.
    Tan C; Li Y; Wang K; Lin Y; Chen Y; Zheng X
    BMC Med Genomics; 2024 May; 17(1):138. PubMed ID: 38778378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dissecting the shared genetic landscape of anxiety, depression, and schizophrenia.
    Tao Y; Zhao R; Yang B; Han J; Li Y
    J Transl Med; 2024 Apr; 22(1):373. PubMed ID: 38637810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mendelian Randomization Study Using Dopaminergic Neuron-Specific eQTL Identifies Novel Risk Genes for Schizophrenia.
    Dang X; Liu J; Zhang Z; Luo XJ
    Mol Neurobiol; 2023 Mar; 60(3):1537-1546. PubMed ID: 36517655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure.
    Rasooly D; Peloso GM; Pereira AC; Dashti H; Giambartolomei C; Wheeler E; Aung N; Ferolito BR; Pietzner M; Farber-Eger EH; Wells QS; Kosik NM; Gaziano L; Posner DC; Bento AP; Hui Q; Liu C; Aragam K; Wang Z; Charest B; Huffman JE; Wilson PWF; Phillips LS; Whittaker J; Munroe PB; Petersen SE; Cho K; Leach AR; Magariños MP; Gaziano JM; ; Langenberg C; Sun YV; Joseph J; Casas JP
    Nat Commun; 2023 Jul; 14(1):3826. PubMed ID: 37429843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identifying therapeutic targets for breast cancer: insights from systematic Mendelian randomization analysis.
    Yao T; Lin YL; Wu YQ; Qian XG; Wang ZN; Qian S; Jiang T; Liu JC; Fang LX; Zhen C; Wu CH
    Front Oncol; 2024; 14():1407795. PubMed ID: 38887235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoimmune thyroid disease and myasthenia gravis: a study bidirectional Mendelian randomization.
    Wang S; Wang K; Chen X; Chen D; Lin S
    Front Endocrinol (Lausanne); 2024; 15():1310083. PubMed ID: 38405140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A genome-wide association study of myasthenia gravis.
    Renton AE; Pliner HA; Provenzano C; Evoli A; Ricciardi R; Nalls MA; Marangi G; Abramzon Y; Arepalli S; Chong S; Hernandez DG; Johnson JO; Bartoccioni E; Scuderi F; Maestri M; Gibbs JR; Errichiello E; Chiò A; Restagno G; Sabatelli M; Macek M; Scholz SW; Corse A; Chaudhry V; Benatar M; Barohn RJ; McVey A; Pasnoor M; Dimachkie MM; Rowin J; Kissel J; Freimer M; Kaminski HJ; Sanders DB; Lipscomb B; Massey JM; Chopra M; Howard JF; Koopman WJ; Nicolle MW; Pascuzzi RM; Pestronk A; Wulf C; Florence J; Blackmore D; Soloway A; Siddiqi Z; Muppidi S; Wolfe G; Richman D; Mezei MM; Jiwa T; Oger J; Drachman DB; Traynor BJ
    JAMA Neurol; 2015 Apr; 72(4):396-404. PubMed ID: 25643325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bidirectional association between hypothyroidism and myasthenia gravis: a Mendelian randomized study.
    Bao Y; Wang L; Cui C; Yu F; Yang J; Huang D
    Neurol Res; 2024 Jan; 46(1):72-80. PubMed ID: 37695759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mendelian randomization study revealed a gut microbiota-neuromuscular junction axis in myasthenia gravis.
    Shi J; Yi M; Xie S; Wang Z; Zhang X; Tan X; Tao D; Liu Y; Yang Y
    Sci Rep; 2024 Jan; 14(1):2473. PubMed ID: 38291090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study.
    Chia R; Saez-Atienzar S; Murphy N; Chiò A; Blauwendraat C; ; Roda RH; Tienari PJ; Kaminski HJ; Ricciardi R; Guida M; De Rosa A; Petrucci L; Evoli A; Provenzano C; Drachman DB; Traynor BJ
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35074870
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of potential drug targets for varicose veins: a Mendelian randomization analysis.
    Lin J; Zhou J; Liu Z; Zeng R; Wang L; Li F; Cui L; Zheng Y
    Front Cardiovasc Med; 2023; 10():1126208. PubMed ID: 37404740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses.
    Zhang W; Ma L; Zhou Q; Gu T; Zhang X; Xing H
    Diabetes; 2024 Apr; 73(4):618-627. PubMed ID: 38211557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identifying potential drug targets for varicose veins through integration of GWAS and eQTL summary data.
    Cui Y; Hu M; Zhou H; Guo J; Wang Q; Xu Z; Chen L; Zhang W; Tang S
    Front Genet; 2024; 15():1385293. PubMed ID: 38818040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of pleiotropic and specific therapeutic targets for cardio-cerebral diseases: A large-scale proteome-wide mendelian randomization and colocalization study.
    Zhu Y; Wang Y; Cui Z; Liu F; Hu J
    PLoS One; 2024; 19(5):e0300500. PubMed ID: 38820305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mendelian randomization and clinical trial evidence supports TYK2 inhibition as a therapeutic target for autoimmune diseases.
    Yuan S; Wang L; Zhang H; Xu F; Zhou X; Yu L; Sun J; Chen J; Ying H; Xu X; Yu Y; Spiliopoulou A; Shen X; Wilson J; Gill D; Theodoratou E; Larsson SC; Li X
    EBioMedicine; 2023 Mar; 89():104488. PubMed ID: 36842216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization.
    Henry A; Gordillo-Marañón M; Finan C; Schmidt AF; Ferreira JP; Karra R; Sundström J; Lind L; Ärnlöv J; Zannad F; Mälarstig A; Hingorani AD; Lumbers RT;
    Circulation; 2022 Apr; 145(16):1205-1217. PubMed ID: 35300523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19.
    Hernández Cordero AI; Li X; Milne S; Yang CX; Bossé Y; Joubert P; Timens W; van den Berge M; Nickle D; Hao K; Sin DD
    Hum Genet; 2021 Jun; 140(6):969-979. PubMed ID: 33604698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteome-Wide Mendelian Randomization Identifies Causal Links Between Blood Proteins and Acute Pancreatitis.
    Bourgault J; Abner E; Manikpurage HD; Pujol-Gualdo N; Laisk T; ; Gobeil É; Gagnon E; Girard A; Mitchell PL; Thériault S; Esko T; Mathieu P; Arsenault BJ
    Gastroenterology; 2023 May; 164(6):953-965.e3. PubMed ID: 36736436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Herpesvirus entry mediator on T cells as a protective factor for myasthenia gravis: A Mendelian randomization study.
    Zhong H; Jiao K; Huan X; Zhao R; Su M; Goh LY; Zheng X; Zhou Z; Luo S; Zhao C
    Front Immunol; 2022; 13():931821. PubMed ID: 35979348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.